Niclosamide, having a higher affinity for GSS due to its lower binding energy, competitively binds to GSS in leukemia cells, reducing the binding of GSS to ATP, thereby decreasing GSH synthesis and promoting ROS accumulation (Hamdoun et al. 2017). The gene discussed is GSS; the disease is leukemia.